Kobayashi Yuhei, Okura Hiroyuki, Kume Teruyoshi, Yamada Ryotaro, Kobayashi Yukari, Fukuhara Kenzo, Koyama Terumasa, Nezuo Shintaro, Neishi Yoji, Hayashida Akihiro, Kawamoto Takahiro, Yoshida Kiyoshi
Kawasaki Medical School.
Circ J. 2014;78(9):2209-14. doi: 10.1253/circj.cj-14-0108. Epub 2014 Jul 14.
Stent underexpansion remains a concern as a cause of drug-eluting stent (DES) failure. Although coronary calcification is considered to be a contributing factor in stent underexpansion, previous intravascular ultrasound studies have failed to demonstrate this relationship. We investigated whether stent expansion could be predicted by coronary calcification as assessed by optical coherence tomography (OCT). METHODS AND RESULTS: We enrolled 51 de novo native coronary artery lesions treated by a single 2nd-generation DES (3 types). Prior to stent deployment, the arc and area of calcium at the target lesion were measured using OCT. After successful stent implantation, OCT imaging was repeated to assess minimal stent diameter and area (MSD and MSA). Stent expansion was defined as MSD (or MSA) divided by the values predicted by the manufacturers' compliance charts. Patients were divided into 4 groups according to the median values of the arc and area of calcium. Mean stent expansion was 73.3±8.7% for MSD and 65.2±12.0% for MSA. Stent expansion defined by MSD was significantly different among the 4 groups (P=0.02). A similar trend was observed for stent expansion defined by MSA (P=0.16).
The extent of target lesion calcification as assessed by OCT may be an important determinant of the expansion of 2nd-generation DES.
支架扩张不足仍是药物洗脱支架(DES)失败的一个原因。尽管冠状动脉钙化被认为是支架扩张不足的一个促成因素,但先前的血管内超声研究未能证实这种关系。我们研究了光学相干断层扫描(OCT)评估的冠状动脉钙化是否可预测支架扩张情况。
我们纳入了51例由单一第二代DES(3种类型)治疗的初发天然冠状动脉病变。在支架置入前,使用OCT测量靶病变处的钙化弧度和面积。成功植入支架后,重复进行OCT成像以评估最小支架直径和面积(MSD和MSA)。支架扩张定义为MSD(或MSA)除以制造商合规图表预测的值。根据钙化弧度和面积的中位数将患者分为4组。MSD的平均支架扩张率为73.3±8.7%,MSA为65.2±12.0%。4组间以MSD定义的支架扩张存在显著差异(P = 0.02)。以MSA定义的支架扩张也观察到类似趋势(P = 0.16)。
OCT评估的靶病变钙化程度可能是第二代DES扩张的一个重要决定因素。